273 related articles for article (PubMed ID: 16932890)
1. Quantitative structure-activity relationship (QSAR) studies of quinolone antibacterials against M. fortuitum and M. smegmatis using theoretical molecular descriptors.
Bagchi MC; Mills D; Basak SC
J Mol Model; 2007 Jan; 13(1):111-20. PubMed ID: 16932890
[TBL] [Abstract][Full Text] [Related]
2. On an aspect of calculated molecular descriptors in QSAR studies of quinolone antibacterials.
Ghosh P; Thanadath M; Bagchi MC
Mol Divers; 2006 Aug; 10(3):415-27. PubMed ID: 16896544
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial design and virtual screening of potent anti-tubercular fluoroquinolone and isothiazoloquinolone compounds utilizing QSAR and pharmacophore modelling.
Nandi S; Ahmed S; Saxena AK
SAR QSAR Environ Res; 2018 Feb; 29(2):151-170. PubMed ID: 29347843
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of the quinolone antibacterials against mycobacteria: effect of structural changes at N-1 and C-7.
Renau TE; Sanchez JP; Gage JW; Dever JA; Shapiro MA; Gracheck SJ; Domagala JM
J Med Chem; 1996 Feb; 39(3):729-35. PubMed ID: 8576916
[TBL] [Abstract][Full Text] [Related]
5. A QSAR study of HIV protease inhibitors using theoretical descriptors.
Basak SC; Mills D; Garg R; Bhhatarai B
Curr Comput Aided Drug Des; 2010 Dec; 6(4):269-82. PubMed ID: 20883201
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents.
Abdelrahman MA; Salama I; Gomaa MS; Elaasser MM; Abdel-Aziz MM; Soliman DH
Eur J Med Chem; 2017 Sep; 138():698-714. PubMed ID: 28715707
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of graphical invariants in quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Bagchi MC; Maiti BC; Mills D; Basak SC
J Mol Model; 2004 Apr; 10(2):102-11. PubMed ID: 14691675
[TBL] [Abstract][Full Text] [Related]
8. On the physical interpretation of QSAR models.
Stanton DT
J Chem Inf Comput Sci; 2003; 43(5):1423-33. PubMed ID: 14502475
[TBL] [Abstract][Full Text] [Related]
9. Purification and inhibition by quinolones of DNA gyrases from Mycobacterium avium, Mycobacterium smegmatis and Mycobacterium fortuitum bv. peregrinum.
Guillemin I; Sougakoff W; Cambau E; Revel-Viravau V; Moreau N; Jarlier V
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2527-2532. PubMed ID: 10517605
[TBL] [Abstract][Full Text] [Related]
10. Purified compounds and extracts from Euclea species with antimycobacterial activity against Mycobacterium bovis and fast-growing mycobacteria.
McGaw LJ; Lall N; Hlokwe TM; Michel AL; Meyer JJ; Eloff JN
Biol Pharm Bull; 2008 Jul; 31(7):1429-33. PubMed ID: 18591787
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of N-substituted 2-[(1E)-alkenyl]-4-(1H)-quinolone derivatives as antimycobacterial agents against non-tubercular mycobacteria.
Wube AA; Bucar F; Hochfellner C; Blunder M; Bauer R; Hüfner A
Eur J Med Chem; 2011 Jun; 46(6):2091-101. PubMed ID: 21429630
[TBL] [Abstract][Full Text] [Related]
12. A quantitative structure-activity relationship (QSAR) study of dermal absorption using theoretical molecular descriptors.
Basak SC; Mills D; Mumtaz MM
SAR QSAR Environ Res; 2007; 18(1-2):45-55. PubMed ID: 17365958
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial evaluation of a new series of N-Alkyl-2-alkynyl/(E)-alkenyl-4-(1H)-quinolones.
Wube A; Guzman JD; Hüfner A; Hochfellner C; Blunder M; Bauer R; Gibbons S; Bhakta S; Bucar F
Molecules; 2012 Jul; 17(7):8217-40. PubMed ID: 22777190
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, antibacterial evaluation and QSAR studies of 7-[4-(5-aryl-1,3,4-oxadiazole-2-yl)piperazinyl] quinolone derivatives.
Kumar R; Kumar A; Jain S; Kaushik D
Eur J Med Chem; 2011 Sep; 46(9):3543-50. PubMed ID: 21689870
[TBL] [Abstract][Full Text] [Related]
15. In vitro interaction of some drug combinations to inhibit rapidly growing mycobacteria isolates from cats and dogs and these isolates' susceptibility to cefovecin and clofazimine.
Bennie CJ; To JL; Martin PA; Govendir M
Aust Vet J; 2015; 93(1-2):40-5. PubMed ID: 25622709
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of extracts and constituents of Pelagonium against rapidly growing mycobacteria.
Seidel V; Taylor PW
Int J Antimicrob Agents; 2004 Jun; 23(6):613-9. PubMed ID: 15194133
[TBL] [Abstract][Full Text] [Related]
17. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
18. Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings.
Malik R; Wigney DI; Dawson D; Martin P; Hunt GB; Love DN
J Feline Med Surg; 2000 Mar; 2(1):35-48. PubMed ID: 11716590
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Lipophilicity of some Quinolone Derivatives by using Quantitative Structure-Activity Relationship.
Shirmohammadi M; Mohammadinasab E; Bayat Z
Curr Drug Discov Technol; 2021; 18(1):83-94. PubMed ID: 31701848
[TBL] [Abstract][Full Text] [Related]
20. Prediction of human blood: air partition coefficient: a comparison of structure-based and property-based methods.
Basak SC; Mills D; Hawkins DM; El-Masri HA
Risk Anal; 2003 Dec; 23(6):1173-84. PubMed ID: 14641892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
